期刊文献+

肝细胞-胆管细胞混合型肝癌的诊治进展 被引量:11

Patients with both hepatocellular and cholangiocarcinoma and their clinicopathological features
原文传递
导出
摘要 肝细胞-胆管细胞混合型肝癌(HCC-CC)是一少见的特殊类型的原发性肝癌。根据wH0肿瘤分类定义,HCC—CC为肝细胞癌与胆管细胞癌共存于同一肝脏同一瘤体中。在HCC-CC中,两种肿瘤成分的并存比例及形式存在高度异质性。确定性HCC—CC病理诊断,必须建立在明确的HCC和CC分化证据之上,通常可借助于免疫组化、粘液染色和电镜检查等手段。根据临床症状不能作出HCC-CC诊断,其影像学表现亦无特征性。虽然部分病例可出现AFP和CA19—9同时升高,但确诊仍有待术后病理诊断。HCC—CC的临床特点,既类似HCC常合并肝炎病毒和门静脉癌栓,又像ICC具有血供差、淋巴结转移等特点。HCC—CC的预后一般较HCC差,但与ICC相比结论不一。本文对HCC-CC近年来的诊治进展作一综述。 Combined hepatocellular and eholangiocar- cinoma (HCC-CC) is a unique primary epithelial tumor of the liver classified by the World Health Organization (WHO) as a tumor containing elements of both hepatocellu- lar carcinoma (HCC) and cholangiocarcinoma (CC). The clinical diagnosis is established by histopathology and a firm pathological diagnosis from definitive evidence of HCC and CC differentiation. HCC-CC's clinical features tend to re- semble hepatocellular carcinoma in regards to venous infiltra- tion and like cholangiocarcinoma with respect to lymph node metastasis. To date, the biological behavior of HCC-CC re- mains ill-defined; however its prognosis seems to be worse than just HCC. Conversely, it is unclear whether the prog- nosis of HCC-CC is better than that of only ICC. This paper reviews recent studies on the clinicopathological behavior of HCC-CC.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2012年第7期561-563,共3页 Chinese Journal of Hepatobiliary Surgery
基金 本课题受上海市卫生局青年基金项目资助(20114Y192)
关键词 肝细胞-胆管细胞混合型肝癌 病理诊断分型 临床特点 预后 Combined hepatocellular and cholangio- carcinoma Pathological diagnosis and classification Clinical characteristics Prognoses
  • 相关文献

参考文献4

二级参考文献62

  • 1Zuo, Huai-Quan,Yan, Lu-Nan,Zeng, Yong,Yang, Jia-Ying,Luo, Hong-Zhi,Liu, Jiang-Wen,Zhou, Li-Xin.Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2007,6(2):161-165. 被引量:13
  • 2黄亮,晏建军,周飞国,储开建,吴孟超,严以群.混合细胞型肝癌临床特点分析[J].肝胆外科杂志,2005,13(5):355-357. 被引量:3
  • 3梅铭惠,陈谦,杨景红,徐静,邱维加,曾思恩,唐建华.肝癌合并门静脉癌栓的临床病理分级及意义[J].中华肝胆外科杂志,2006,12(6):374-377. 被引量:16
  • 4Louis Libbrecht.Hepatic progenitor cells in human liver tumor development[J].World Journal of Gastroenterology,2006,12(39):6261-6265. 被引量:24
  • 5[35]Aishima S,Kuroda Y,Asayama Y,Taguchi K,Nishihara Y,Taketomi A,Tsuneyoshi M.Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma.Hum Pathol 2006; 37:283-291
  • 6[36]Tanaka S,Yamamoto T,Tanaka H,Kodai S,Ogawa M,Ichikawa T,Hai S,Sakabe K,Uenishi T,Shuto T,Kubo S.Potentiality of combined hepatocellular and intrahepatic cholangiocellular carcinoma originating from a hepatic precursor cell:Immunohistochemical evidence.Hepatol Res 2005; 32:52-57
  • 7[37]Kim H,Park C,Han KH,Choi J,Kim YB,Kim JK,Park YN.Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype.J Hepatol 2004; 40:298-304
  • 8[38]Robrechts C,De Vos R,Van den Heuvel M,Van Cutsem E,Van Damme B,Desmet V,Roskams T.Primary liver tumour of intermediate (hepatocyte bile duct cell) phenotype:a progenitor cell tumour? Liver 1998; 18:288-293
  • 9[39]Koh KC,Lee H,Choi MS,Lee JH,Paik SW,Yoo BC,Rhee JC,Cho JW,Park CK,Kim HJ.Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma.Am J Surg 2005; 189:120-125
  • 10[40]Yano Y,Yamamoto J,Kosuge T,Sakamoto Y,Yamasaki S,Shimada K,Ojima H,Sakamoto M,Takayama T,Makuuchi M.Combined hepatocellular and cholangiocarcinoma:a clinicopathologic study of 26 resected cases.Jpn J Clin Oncol 2003; 33:283-287

共引文献50

同被引文献103

引证文献11

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部